Mapping and ablation procedures for the treatment of ventricular tachycardia

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Ventricular tachycardia (VT) may occur in the presence or absence of structural heart disease. Given that the management of VT hinges on the presence of symptoms and risk of sudden cardiac death (SCD), the main treatment goals are elimination of symptoms (including frequent implantable cardioverter defibrillator [ICD] therapies) and prevention of SCD. Unfortunately, medical management is suboptimal in a significant proportion of patients. As such, ablative therapy plays a prominent role in the treatment of ventricular tachycardia. Areas covered: In this review, we will discuss various VT disorders that are encountered in patients with and without structural heart disease. Further, we will highlight salient features regarding mapping and ablation of the various VT syndromes. Finally, we will discuss what lies on the horizon for VT ablation. Expert commentary: Meticulous mapping should aim to find the region that is most likely to be successful and least likely to result in a complication. Although recognition of the various mechanisms of VT, familiarity with different methods to mapping and ablation, and awareness of potential limitations of current approaches is critical, a thorough understanding of the fundamental principles and nuances of each facet within EP is required to ensure optimal outcomes for our patients.

Original languageEnglish (US)
Pages (from-to)1071-1087
Number of pages17
JournalExpert Review of Cardiovascular Therapy
Volume14
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Ventricular Tachycardia
Sudden Cardiac Death
Therapeutics
Heart Diseases
Play Therapy
Implantable Defibrillators

Keywords

  • ablation
  • activation mapping
  • endocavitary
  • entrainment
  • fascicular
  • mapping
  • outflow
  • radiofrequency
  • scar
  • substrate mapping
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Mapping and ablation procedures for the treatment of ventricular tachycardia. / Killu, Ammar M.; Mulpuru, Siva; Asirvatham, Samuel J.

In: Expert Review of Cardiovascular Therapy, Vol. 14, No. 9, 01.09.2016, p. 1071-1087.

Research output: Contribution to journalReview article

@article{38b4baf84c3442af823ba78fb18ec90c,
title = "Mapping and ablation procedures for the treatment of ventricular tachycardia",
abstract = "Introduction: Ventricular tachycardia (VT) may occur in the presence or absence of structural heart disease. Given that the management of VT hinges on the presence of symptoms and risk of sudden cardiac death (SCD), the main treatment goals are elimination of symptoms (including frequent implantable cardioverter defibrillator [ICD] therapies) and prevention of SCD. Unfortunately, medical management is suboptimal in a significant proportion of patients. As such, ablative therapy plays a prominent role in the treatment of ventricular tachycardia. Areas covered: In this review, we will discuss various VT disorders that are encountered in patients with and without structural heart disease. Further, we will highlight salient features regarding mapping and ablation of the various VT syndromes. Finally, we will discuss what lies on the horizon for VT ablation. Expert commentary: Meticulous mapping should aim to find the region that is most likely to be successful and least likely to result in a complication. Although recognition of the various mechanisms of VT, familiarity with different methods to mapping and ablation, and awareness of potential limitations of current approaches is critical, a thorough understanding of the fundamental principles and nuances of each facet within EP is required to ensure optimal outcomes for our patients.",
keywords = "ablation, activation mapping, endocavitary, entrainment, fascicular, mapping, outflow, radiofrequency, scar, substrate mapping, Ventricular tachycardia",
author = "Killu, {Ammar M.} and Siva Mulpuru and Asirvatham, {Samuel J}",
year = "2016",
month = "9",
day = "1",
doi = "10.1080/14779072.2016.1186541",
language = "English (US)",
volume = "14",
pages = "1071--1087",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Mapping and ablation procedures for the treatment of ventricular tachycardia

AU - Killu, Ammar M.

AU - Mulpuru, Siva

AU - Asirvatham, Samuel J

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Introduction: Ventricular tachycardia (VT) may occur in the presence or absence of structural heart disease. Given that the management of VT hinges on the presence of symptoms and risk of sudden cardiac death (SCD), the main treatment goals are elimination of symptoms (including frequent implantable cardioverter defibrillator [ICD] therapies) and prevention of SCD. Unfortunately, medical management is suboptimal in a significant proportion of patients. As such, ablative therapy plays a prominent role in the treatment of ventricular tachycardia. Areas covered: In this review, we will discuss various VT disorders that are encountered in patients with and without structural heart disease. Further, we will highlight salient features regarding mapping and ablation of the various VT syndromes. Finally, we will discuss what lies on the horizon for VT ablation. Expert commentary: Meticulous mapping should aim to find the region that is most likely to be successful and least likely to result in a complication. Although recognition of the various mechanisms of VT, familiarity with different methods to mapping and ablation, and awareness of potential limitations of current approaches is critical, a thorough understanding of the fundamental principles and nuances of each facet within EP is required to ensure optimal outcomes for our patients.

AB - Introduction: Ventricular tachycardia (VT) may occur in the presence or absence of structural heart disease. Given that the management of VT hinges on the presence of symptoms and risk of sudden cardiac death (SCD), the main treatment goals are elimination of symptoms (including frequent implantable cardioverter defibrillator [ICD] therapies) and prevention of SCD. Unfortunately, medical management is suboptimal in a significant proportion of patients. As such, ablative therapy plays a prominent role in the treatment of ventricular tachycardia. Areas covered: In this review, we will discuss various VT disorders that are encountered in patients with and without structural heart disease. Further, we will highlight salient features regarding mapping and ablation of the various VT syndromes. Finally, we will discuss what lies on the horizon for VT ablation. Expert commentary: Meticulous mapping should aim to find the region that is most likely to be successful and least likely to result in a complication. Although recognition of the various mechanisms of VT, familiarity with different methods to mapping and ablation, and awareness of potential limitations of current approaches is critical, a thorough understanding of the fundamental principles and nuances of each facet within EP is required to ensure optimal outcomes for our patients.

KW - ablation

KW - activation mapping

KW - endocavitary

KW - entrainment

KW - fascicular

KW - mapping

KW - outflow

KW - radiofrequency

KW - scar

KW - substrate mapping

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84983445371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983445371&partnerID=8YFLogxK

U2 - 10.1080/14779072.2016.1186541

DO - 10.1080/14779072.2016.1186541

M3 - Review article

VL - 14

SP - 1071

EP - 1087

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 9

ER -